HeartLung AI-CVD®

by HeartLung Corporation — AI-powered quantitative imaging for cardiovascular and multisystem risk assessment.
Cardiology Internal Medicine preventive-medicine
Claim this tool

Enterprise
Regulatory Status Disclosed

Overview

HeartLung AI-CVD® is an FDA-cleared, opportunistic AI-powered quantitative imaging tool designed to assist physicians in assessing cardiovascular and multisystem risks. Leveraging existing CT scans, AI-CVD® automatically provides anatomical and density-based measurements that can reveal early indicators of various health conditions.

The tool integrates seamlessly into clinical workflows, analyzing non-gated, non-contrast CT scans (such as those performed for lung cancer screening or other indications) to extract valuable data. This opportunistic screening approach allows for the identification of at-risk patients without requiring additional imaging procedures or radiation exposure, making it a highly efficient and patient-friendly solution.

For physicians, AI-CVD® offers a powerful adjunct to traditional diagnostic methods, providing objective, reproducible measurements that can inform preventative strategies and personalized treatment plans. Its ability to detect subtle changes in cardiovascular structures and tissue densities can lead to earlier interventions and improved patient outcomes across a range of specialties.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • Automated CT-derived measurements
  • Opportunistic screening from existing CT scans
  • Quantitative anatomical analysis
  • Density-based risk assessment
  • FDA-cleared for cardiovascular and multisystem risks
  • Non-gated, non-contrast CT analysis
  • Integration into clinical workflows

Use Cases

  • Early detection of cardiovascular disease
  • Risk stratification for heart disease
  • Identification of patients for preventative interventions
  • Assessment of multisystem health risks from CT scans
  • Population health screening for at-risk individuals
  • Enhancing diagnostic capabilities in radiology and cardiology

Details

Category Cardiology AI, Clinical Decision Support & Reference, Radiology & Imaging AI
Pricing Enterprise Enterprise custom pricing
DeploymentCloud
Mobile AppNone
Data Export Yes
LanguagesEnglish
Training Yes
Target SizeLarge health systems
Compliance
BAA Available Yes AI-estimated
HIPAA Compliant Yes AI-estimated
FDA Status Cleared AI-estimated — K220709
Integrations
EHR Not specified
Specialties Cardiology, Internal Medicine, Preventive Medicine, Pulmonology, Radiology

Social Proof

Customersunknown
Notable
unknown

Support & Reliability

Training Provided Yes

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate HeartLung AI-CVD®

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money
No press coverage or publications on file yet. Know of some? Suggest an edit →

Videos

Product demos, reviews, and walkthroughs for HeartLung AI-CVD®.

Loading videos...

View all on YouTube

No FAQs available yet for this tool.

Related Tools

Heartvue.Proton
Heartvue.ai
Cardiology AI
Heartvue.ai provides AI-powered software for automating cardiac MRI analysis and optimizing echocardiography documentation and revenue.
Cleerly
Cleerly, Inc.
Cardiology AI
Cleerly is an FDA-cleared AI platform that analyzes coronary CT scans to quantify plaque volume, characterize plaque morphology, and assess ischemia.
Cardiomatics
Cardiomatics
Cardiology AI
Cardiomatics is a cloud-based, AI-powered software for analyzing ambulatory (Holter) ECG tests, using clinically validated algorithms to provide accurate and high-quality results for cardiac diagnostics. It aims to streamline ECG analysis, reduce interpretation time, and improve diagnostic accuracy for various heart conditions.
SafeBeat Rx App
SafeBeat Rx, Inc.
Cardiology AI
An AI application designed to support safe pharmacological treatment and monitoring for cardiac arrhythmias.
PreemptiveAI Clinical SDK
Measure Labs, Inc. (Dba Preemptiveai, Inc.)
Cardiology AI
A clinical software development kit using AI to model and predict cardiovascular health metrics, aiming to shift healthcare from reactive to proactive by providing early health risk signals.
Clarius Ejection Fraction AI
Clarius Mobile Health Corp.
Cardiology AI
Clarius Ejection Fraction AI is an AI-powered ultrasound tool for automated left ventricular ejection fraction calculation, integrated into the Clarius Ultrasound App for real-time cardiac assessments.

See all Cardiology AI tools →

Suggest an Edit → | Last Verified: 2026-09-17 | First Added: 2026-09-17
AI Tool Finder
AI-powered search. Results may not be comprehensive.